Cardinal Health Inc. logo

Cardinal Health Inc. (CAH)

Market Closed
2 Jul, 20:00
NYSE NYSE
$
161. 98
-2.42
-1.47%
$
39.9B Market Cap
164.74 P/E Ratio
2.02% Div Yield
3,129,500 Volume
5.74 Eps
$ 164.4
Previous Close
Day Range
161.65 164.25
Year Range
93.17 168.44
Want to track CAH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 35 days
Cardinal Health (CAH) Stock Falls Amid Market Uptick: What Investors Need to Know

Cardinal Health (CAH) Stock Falls Amid Market Uptick: What Investors Need to Know

In the most recent trading session, Cardinal Health (CAH) closed at $161.98, indicating a -1.47% shift from the previous trading day.

Zacks | 10 hours ago
5 Strong Buy-Rated Dividend Stocks Are Among the S&P 500 Top Performers in 2025

5 Strong Buy-Rated Dividend Stocks Are Among the S&P 500 Top Performers in 2025

Dividend stocks are a favorite among investors for good reason.

247wallst | 22 hours ago
Cardinal Health (CAH) is a Great Momentum Stock: Should You Buy?

Cardinal Health (CAH) is a Great Momentum Stock: Should You Buy?

Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 1 day ago
Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 5 days ago
Cardinal Health (CAH) Laps the Stock Market: Here's Why

Cardinal Health (CAH) Laps the Stock Market: Here's Why

In the closing of the recent trading day, Cardinal Health (CAH) stood at $165.61, denoting a +1.14% move from the preceding trading day.

Zacks | 6 days ago
Wall Street Bulls Look Optimistic About Cardinal (CAH): Should You Buy?

Wall Street Bulls Look Optimistic About Cardinal (CAH): Should You Buy?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks | 1 week ago
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?

Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 1 week ago
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?

Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 weeks ago
Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy?

Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 weeks ago
Cardinal Health raises annual profit target

Cardinal Health raises annual profit target

Drug distributor Cardinal Health raised its annual adjusted profit forecast on Thursday, banking on demand for costly specialty medicines and branded drugs at its pharmaceuticals unit.

Reuters | 2 weeks ago
Cardinal Health Details Momentum and Updated Long-Term Value Creation Plans at Investor Day

Cardinal Health Details Momentum and Updated Long-Term Value Creation Plans at Investor Day

Key announcements: Raising FY25 non-GAAP diluted EPS guidance to $8.15 to $8.20 1 Establishing preliminary FY26 non-GAAP diluted EPS guidance of $9.10 to $9.30 (13% growth at the mid-points)2 Confirming long-term target of 12% to 14% non-GAAP diluted EPS CAGR for FY26 to FY283 Raising long-term target for Pharmaceutical and Specialty Solutions profit to 5% to 7% normalized growth3,4 Raising long-term target for Other profit to ~10% normalized growth3,4,5 Updating GMPD long-term target to $50M+ of profit growth per year after FY26 Expecting at least $10B in total adjusted free cash flow over next three years Raising baseline share repurchase plans to at least $750M per year Company reiterating strategic priorities and providing updates across its businesses DUBLIN, Ohio , June 12, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today will host an Investor Day beginning at 9:00 a.m. ET, where management will detail its growth strategies to maximize the company's potential for all stakeholders.

Prnewswire | 2 weeks ago
Cardinal Health launches new medical device for the continuous monitoring of three essential vital signs in one system

Cardinal Health launches new medical device for the continuous monitoring of three essential vital signs in one system

Kendall DLâ„¢ Multi System simplifies patient monitoring, drives efficiencies for providers  DUBLIN, Ohio , June 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its multi-parameter, single-patient use monitoring cable and lead wire system that enables the continuous monitoring of cardiac activity, blood oxygen level and temperature with one point of connection. The new Kendall DLâ„¢ Multi System is designed to travel with the patient from admission to discharge for smooth transport.

Prnewswire | 4 weeks ago
Loading...
Load More